No connection

Search Results

Corporate Score 32 Bullish

Chewy Targets Margin Expansion Through Subscription and Healthcare Integration

Apr 19, 2026 21:50 UTC
CHWY
Long term

Online pet retailer Chewy is leveraging its Autoship program and expanding healthcare services to drive profitability. The company aims for a long-term EBITDA margin of 10% through diversified revenue streams.

  • Autoship sales reached 84% of total Q4 revenue
  • Acquisition of Modern Animal adds 29 clinics to the network
  • Adjusted EBITDA margin increased from 4.8% to 5.7%
  • Long-term EBITDA margin goal set at 10%
  • Enterprise value currently at $10.5 billion

Chewy (NYSE: CHWY) is shifting its strategic focus toward operating margin expansion, utilizing a combination of subscription services and high-margin business lines to boost the bottom line. The company is currently leveraging three primary growth pillars: its Autoship subscription model, a growing retail media advertising business, and an expanding physical healthcare footprint. These initiatives are designed to create a growth flywheel, increasing customer lifetime value while reducing operational costs. The Autoship program has become central to the business, accounting for 84% of sales in the fourth quarter, up from 80.6% in the prior year. This model allows for better inventory management and shipping efficiencies. Simultaneously, Chewy is scaling its healthcare presence. As of early April, the company operated 18 Vet Care clinics and recently expanded its reach by acquiring Modern Animal, adding 29 more locations. This physical expansion integrates clinics with Chewy's online pharmacy, enabling a seamless ecosystem for prescriptions and retail orders. From a financial perspective, Chewy's adjusted EBITDA margin rose to 5.7% last year, compared to 4.8% the previous year. Management has set a long-term target of 10%, which would represent significant growth in EBITDA even in a scenario of stagnant revenue. Currently trading at $27 with an enterprise value of $10.5 billion, the stock is valued at approximately 11.4 times the midpoint of management's EBITDA guidance. Investors are monitoring whether the company can successfully scale its high-margin advertising and clinic segments to meet these profitability goals.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Share this article

Related Articles

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Home
Terminal
AI
Markets
Profile